Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1910 for “"Lymphoma"”.
-
Mantle cell lymphoma pathogenesis
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival time of 3 years. Although the characteristic t(11;14)(q13;q32) is found in virtually all cases, experimental evidence suggests that this event alone is insufficient to result in lymphoma and secondary …
-
Oncolytic Viruses in Lymphoma
Lymphoma is a heterogenous disease accounting for 4% of all UK cancer diagnoses. Its overall response to chemotherapy is good. However, in patients with relapsed or refractory disease, less than half will obtain durable remissions. Anti CD20 targeting by monoclonal antibodies such as rituximab have …
-
Burkitt lymphoma and diffuse large B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
Burkitt lymphoma (BL) is a rare, aggressive disorder constituting 1% of all non-Hodgkin lymphoma. Diffuse large B-cell lymphoma (DLBCL) is more common, accounting for 30% of malignant lymphoma. Standard treatment for adult BL and for certain subgroups of patients with DLBCL remains to be defined …
-
The Biology of Mantle Cell Lymphoma: Exploring the Gender Difference in Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a rare B cell neoplasm that accounts for approximately 4-8% of non-Hodgkin’s lymphomas (NHLs). The median age at diagnosis is 65 years with a male to female predominance of 3:1. It has also been demonstrated that female MCL patients have a greater response to therapy, …
-
Burkitt lymphoma classification and MYC-associated non-Burkitt lymphoma investigation based on gene expression
Burkitt lymphoma and diffuse large B-cell lymphoma are two closely related types of lymphoma that are managed differently in clinical practice and the accurate diagnosis is a key point in treatment decisions. However based on current criteria combined with morphological, immunophenotypic and …
-
Molecular characterisation of canine lymphoma
Lymphoma is the most common haematopoietic malignancy of dogs, but little is known about its aetiology and pathogenesis. Canine lymphoma is composed of a clinically heterogeneous group of tumours, as in human non-Hodgkin lymphoma (hNHL), which shares many similarities with the canine disease. In …
-
Transcriptional profiling of aggressive lymphoma
Lymphoma is the fifth most frequent cancer in North America and Western Europe. This thesis is concerned with transcriptional profiling of diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) using supervised and semi-supervised machine learning methodology. It investigates two aspects …
-
Mitochondrial biogenesis and pathway activation during follicular lymphoma transformation to diffuse large B-cell lymphoma
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
-
The Role of NFATc1 in Burkitt Lymphoma and in Eµ-Myc induced B cell Lymphoma
Burkitt lymphoma (BL) is a highly aggressive B cell malignancy. Rituximab, a humanized antibody against CD20, in a combination with chemotherapy is a current treatment of choice for B-cell lymphomas including BL. However, certain group of BL patients are resistant to Rituximab therapy. Therefore, …
-
Aberrant hypermethylation of Xq12 in lymphoma
… located on the X chromosome in 84% of follicular lymphoma patient samples. Methylation has been shown to spread several megabases from its origin and this has led us to hypothesize that a candidate tumour suppressor gene is located in the vicinity ofthe AR. AR and the nearby oligophrenin (OPHNl) …
-
Targeted therapies in mantle cell lymphoma
Mantle cell lymphoma (MCL) is characterized by the presence of the t(11 ;14)(g13 ;g32) translocation which results in cyclin Dl over-expression. MCL is one of the most difficult lymphoproliferative disorders to manage with a median survival rate of 43 months from diagnosis. The poor prognosis …
-
The molecular ontogeny of follicular lymphoma
Background: Advanced-stage follicular lymphoma (FL) is considered incurable, with patients typically suffering from a chronic relapsing clinical course. Relapsed FL is thought to originate from common progenitor cells (CPCs) through divergent evolution. CPCs typically contain the hallmark BCL2/IGH …
-
Fractionated radioimmunotherapy of non-Hodgkin's lymphoma
<p>Impressive durable responses from clinical studies using higher myeloablative dose RIT followed by peripheral blood stem cell transplant (PBSCT) suggest that there may be a radiation dose response for RIT. With the development of rituximab, a chimeric mAb, multiple or fractionated treatments are …
-
Therapeutic DNA vaccination in follicular lymphoma
… in humans in patients with low-grade follicular lymphoma. Twenty-five patients were enrolled and the V genes encoding the V domains of their surface immunoglobulin (sIg) on the dominant malignant clone were isolated from a lymph node biopsy and single chain variable domain antibody fragments …
-
Prognostication of Canine T Cell Lymphoma
Canine lymphoma is a heterogeneous disease with many different subtypes. T cell lymphoma (TCL) is variable in outcome, and includes subtypes with non-progressive, indolent and aggressive disease course. Methods used to categorize lymphoma including cytopathology, flow cytometry, histopathology, and …
Page 1 of 96